MIT & Recursion Unveil Boltz-2, Accelerates Drug Discovery 1000x, Rivals Physics-Based Accuracy

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, a significant advancement in drug discovery was announced with the open-source release of Boltz-2, which is a biomolecular foundation model developed through a collaboration between researchers at the Massachusetts Institute of Technology (or MIT) Computer Science and Artificial Intelligence Lab (or CSAIL) and Jameel Clinic, and the TechBio company Recursion.

Boltz-2 is an AI model that combines the prediction of complex biomolecular structures with binding affinity prediction. It’s a substantial improvement on previous models like AlphaFold3 and its predecessor, called Boltz-1. The model was trained and validated using Recursion’s NVIDIA supercomputer, called BioHive-2, that features 504 NVIDIA H100 GPUs and achieves ~2 exaflops of AI performance.

MIT & Recursion Unveil Boltz-2, Accelerates Drug Discovery 1000x, Rivals Physics-Based Accuracy

A pharmacist in a hospital pharmacy stands next to a row of various drug containers.

Boltz-2 achieves accuracy comparable to physics-based Free Energy Perturbation/FEP calculations, which is an industry-standard method for predicting how strongly molecules bind, but at speeds up to 1000 times faster. This increase in speed and efficiency reduces the cost and time involved in large-scale virtual screening, thereby addressing a bottleneck in the early stages of small-molecule drug discovery.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company that integrates technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the US.

While we acknowledge the potential of RXRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.